Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionSalvage TherapyStem CellsDisease-Free SurvivalRecurrenceEtoposideHodgkin DiseaseCyclophosphamideLymphoma, Non-HodgkinMyeloablative AgonistsCytarabineCarmustineSurvival RateBone Marrow TransplantationGraft vs Host DiseaseHematopoietic Stem Cell MobilizationThiotepaVincristineBone Marrow PurgingSurvival AnalysisHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationRetrospective StudiesAmyloidosisDoxorubicinPrognosisHematopoietic Stem CellsBusulfanBoronic AcidsDexamethasonePyrazinesGraft SurvivalFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic Agents, AlkylatingAntigens, CD34Lymphoma, T-Cell, PeripheralAutograftsLiver TransplantationThalidomideIfosfamideAntineoplastic AgentsTime FactorsInduction ChemotherapyMesenchymal Stem Cell TransplantationPrednisoneGranulocyte Colony-Stimulating FactorLeukapheresisLymphomaPodophyllotoxinNeoplasm, ResidualLymphoma, Large B-Cell, DiffuseTransplantation ChimeraMaintenance ChemotherapyLeukemia, Myeloid, AcuteTissue DonorsCord Blood Stem Cell TransplantationCell TransplantationKidney TransplantationLymphoma, B-CellMyelodysplastic SyndromesMitoxantroneIdarubicinEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsNeoplasms, Second PrimaryLeukemia, Plasma CellInfusions, SpinalCisplatinProspective StudiesNeoplasm Recurrence, LocalCarboplatinAdult Stem CellsBlood Component RemovalImmunosuppressive AgentsChemotherapy, AdjuvantHistocompatibility TestingDrug Administration ScheduleAntibodies, MonoclonalLeukemia, MyeloidFeasibility StudiesFatal OutcomeCell DifferentiationLife TablesKeratins, Type IIHistocompatibilityLeukemia